5[1]Schellhorn C. Classification of quinolones by Ⅴ Andriole[J]. Infection, 1998,26(1):64.
6[2]Chu D T W,Fernandes P B. Structure-activity relationships of the fluoroquinolones[J]. Antimicrob Agents Chemother, 1989,33(2):131-135.
7[3]Stahlmann R,Lode H. Toxicity of quinolones[J]. Drugs,1999,58(suppl.2):37-42.
8[4]Stahlmann R,Schwabe R. Safety profile of grepafloxacin as compared with fluoroquinolones[J]. J Antimicrob Chemother, 1997,40(suppl.A):83-92.
9[5]Stahlmann R. Safety profile of the quinolones[J]. J Antimicrob Chemother, 1990, 26 (Suppl.D):31-44.
10[6]Akahane K,Sekiguchi M,Une T,et al. Structure-epileptogenicity relationships of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites[J]. Antimicrob Agents Chemother, 1989,33(10):1704-1708.
